Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?

Diabetes Care. 2008 Feb:31 Suppl 2:S194-201. doi: 10.2337/dc08-s249.
No abstract available

Publication types

  • Review

MeSH terms

  • Albuminuria / drug therapy
  • Albuminuria / epidemiology
  • Albuminuria / etiology*
  • Antihypertensive Agents / therapeutic use
  • Biomarkers / urine
  • Blood Pressure / physiology
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / urine
  • Clinical Trials as Topic
  • Cohort Studies
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetic Angiopathies / physiopathology
  • Diabetic Angiopathies / urine*
  • Diabetic Nephropathies / physiopathology
  • Diabetic Nephropathies / urine
  • Fosinopril / therapeutic use
  • Glomerular Filtration Rate
  • Humans
  • Hypertension / drug therapy
  • Hypertension / epidemiology
  • Hypertension / urine*
  • Prevalence
  • Proteinuria / etiology

Substances

  • Antihypertensive Agents
  • Biomarkers
  • Fosinopril